Erythrocytosis induced by danazol in an anephric patient.
article
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
An anephric patient developed erythrocytosis and high serum erythropoietin after danazol treatment for menorrhagia, suggesting a hepatic origin for the hormone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Erythrocytosis induced by danazol in an anephric patient An anephric patient undergoing continuous ambulatory peritoneal dialysis developed erythrocytosis after treatment of menorrhagia with danazol; this was associated with a high serum immunoreactive erythropoietin concentra- tion, presumably ofhepatic origin.This may suggest a use for danazol in the treatment of refractory anaemias.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
- THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT 1979
Cited by (2)
References (7)
- THE EFFECT OF DANAZOL ON MENORRHAGIA, COAGULATION MECHANISMS, HAEMATOLOGICAL INDICES AND BODY WEIGHT via openalex
- W2417356717 via openalex
- doi:10.1099/00222615-22-1-57 via openalex
- doi:10.1136/jcp.37.9.1002 via openalex
- doi:10.1111/j.1365-2141.1982.tb01938.x via openalex
- doi:10.7326/0003-4819-79-6-823 via openalex
- doi:10.1159/000182229 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-11T03:38:02.056803+00:00
License: CC0
· commercial use OK